Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FMEA1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,311
Award facts
- Contract value 100% obligated
- $21,311.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $21,311.10 firm fixed-price delivery order (4570226322) by the Defense Logistics Agency for Nexplanon 68 mg implants, a subdermal contraceptive device. This delivery order, issued December 8, 2025, with an ultimate completion date of December 30, 2025, carries no set-aside designation, indicating the award was made through unrestricted competition. The delivery will be performed at the contractor's headquarters location in Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition vehicle designed to streamline pharmaceutical procurement for military healthcare facilities worldwide. The underlying IDC, awarded November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's demonstrated performance across numerous prior delivery orders positions the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMEA1?
SPE2DR26FMEA1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FMEA1 worth?
The government has obligated $21,311 on SPE2DR26FMEA1.
Is contract SPE2DR26FMEA1 an order under another contract?
Yes. SPE2DR26FMEA1 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEA1 competed?
The extent of competition for SPE2DR26FMEA1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award